Bill Maughan
Stock Analyst at Canaccord Genuity
(3.24)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
YMAB Y-mAbs Therapeutics | Downgrades: Hold | 26 9 | 8.54 | 0.7% | 3 | Aug 6, 2025 | |
KRYS Krystal Biotech | Initiates Coverage On: Buy | 190 | 151.97 | 25.02% | 1 | Jul 1, 2025 | |
CRSP CRISPR Therapeutics | Downgrades: Hold | 45 | 54.33 | -17.17% | 1 | Jun 27, 2025 | |
NKTX Nkarta | Maintains: Buy | 16 15 | 2.38 | 530.25% | 2 | May 10, 2024 | |
FATE Fate Therapeutics | Maintains: Buy | 11 9 | 1.15 | 682.61% | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 63 67 | 33.38 | 100.72% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 91 106 | 27.04 | 292.01% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 24 | 0.55 | 4263.64% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 | 7.24 | 728.73% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 67 | -32.84% | 1 | Nov 2, 2023 |